DENATURATION OF HEPATIC-MICROSOMAL CYTOCHROME-P-450 BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS INVITRO

被引：1
作者：
FALZON, M
HOGG, J
MILTON, AS
BURKE, MD
机构：
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 1984年 / 12卷 / 04期
关键词：
D O I：
10.1042/bst0120685
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：685 / 685
页数：1
相关论文
共 9 条
[1]   DECREASED HEPATIC-MICROSOMAL CYTOCHROME-P450 DUE TO INDOMETHACIN - PROTECTIVE ROLES OF 16,16-DIMETHYLPROSTAGLANDIN-F2-ALPHA AND INDUCING AGENTS [J].
BURKE, MD ;
FALZON, M ;
MILTON, AS .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (03) :389-397
[2]   ADVERSE REACTIONS TO NON-STEROIDAL ANTIRHEUMATIC DRUGS [J].
CUTHBERT, MF .
CURRENT MEDICAL RESEARCH AND OPINION, 1974, 2 (09) :600-610
[3]   ARE THE DECREASES IN HEPATIC CYTOCHROME-P-450 AND OTHER DRUG-METABOLIZING-ENZYMES CAUSED BY INDOMETHACIN INVIVO MEDIATED BY INTESTINAL BACTERIAL-ENDOTOXINS - 16,16-DIMETHYLPROSTAGLANDIN-F2-ALPHA PREVENTS DECREASES IN HEPATIC DRUG-METABOLIZING-ENZYMES DUE TO EXOGENOUS ENDOTOXIN [J].
FALZON, M ;
MILTON, AS ;
BURKE, MD .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (08) :1285-1292
[4]   RECONVERSION OF DETERGENT- AND SULFHYDRYL REAGENT- PRODUCED P-420 TO P-450 BY POLYOLS AND GLUTATHIONE [J].
ICHIKAWA, Y ;
YAMANO, T .
BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 131 (03) :490-&
[5]  
KATZ AM, 1965, CLIN PHARMACOL THER, V6, P25
[6]   LIPID PEROXIDATION AND DEGRADATION OF CYTOCHROME-P-450 HEME [J].
LEVIN, W ;
LU, AYH ;
JACOBSON, M ;
KUNTZMAN, R ;
POYER, JL ;
MCCAY, PB .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1973, 158 (02) :842-852
[7]  
OMURA T, 1964, J BIOL CHEM, V239, P2370
[8]   THE ROLE OF LIPID-PEROXIDATION IN CCL4-INDUCED DAMAGE TO LIVER MICROSOMAL-ENZYMES - COMPARATIVE STUDIES INVITRO USING MICROSOMES AND ISOLATED LIVER-CELLS [J].
POLI, G ;
CHEESEMAN, K ;
SLATER, TF ;
DIANZANI, MU .
CHEMICO-BIOLOGICAL INTERACTIONS, 1981, 37 (1-2) :13-24
[9]   CYTOCHROME-P-450 .4. STABILITY OF CYTOCHROME-P-450 AND CONVERSION TO CYTOCHROME P-420 - ISOLATION AND PROPERTIES OF CYTOCHROME P-420 [J].
YAMANO, T ;
ICHIKAWA, Y .
PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS, 1978, 2 (04) :673-692
1